Although currently in its early stages, the literature regarding the role of ERK signaling in depression pathology suggests that ERK more often represents a target for up-regulation in the context of BDNF-induced neurogenesis, rather than a target for down-regulation in the context of mediating inflammation. The gene discussed is BDNF; the disease is major depressive disorder.